Skip to main content
Fachgebiete
Automobil + Motoren Bauwesen + Immobilien Business IT + Informatik Elektrotechnik + Elektronik Energie + Nachhaltigkeit Finance + Banking Management + Führung Marketing + Vertrieb Maschinenbau + Werkstoffe Versicherung + Risiko
DE
EN
Themenseiten
Organisationspsychologie Projektmanagement Marketing Smart Manufacturing
Bücher
Zeitschriften
Weitere Formate
Podcasts Webinare Technik Webinare Wirtschaft Kongresse Veranstaltungskalender Awards
Jetzt Einzelzugang starten
Zugang für Unternehmen
Referenzkunden
ATZ-Fachkongress

Chassis.tech plus 2024


4 Kongresse in einer Veranstaltung

Treffen Sie in München die Fachleute von Chassis, Lenkung, Bremsen sowie Reifen/Räder.
Erweiterte Suche
Anmelden
nach oben
Quality of Life Research
Erschienen in: Quality of Life Research 6/2007

01.08.2007 | Original Paper

Responsiveness to change to change due to supportive-expressive group therapy, improvement in mood and disease progression in women with metastatic breast cancer

verfasst von: Julie Lemieux, Dorcas E. Beaton, Sheilah Hogg-Johnson, Louise J. Bordeleau, Jon Hunter, Pamela J. Goodwin

Erschienen in: Quality of Life Research | Ausgabe 6/2007

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Objective

To compare the responsiveness of six questionnaires using three hypotheses of change: (i) change due to supportive-expressive group therapy (SEGT), (ii) improved mood defined as a small effect size (.2) on Profile of Mood States (POMS) Total Mood Disturbance score and (iii) progression of disease.

Method

Data from the “Breast Expressive-Supportive Therapy” study, a multicentre randomized controlled trial of change due to SEGT versus standard of care in women with metastatic breast cancer were used. Questionnaires studied were: POMS, Impact of Event Scale, Psychosocial Adjustment to Illness Scale (PAIS), EORTC QLQ-C30, Mental Adjustment to Cancer and a Pain visual analog scale (VAS). Responsiveness to change was evaluated using the standardized response mean. POMS was used as the standard.

Results

POMS was the most responsive questionnaire to change due to SEGT. Questionnaires measuring psychosocial attributes were responsive to improvement in mood. EORTC QLQ-C30, PAIS, PAIN VAS and MAC were the most responsive to disease progression. More responsive questionnaires were associated with the smallest sample size required to detect an effect.

Conclusions

Responsiveness to change is context specific. The POMS was the most responsive questionnaire to psychosocial therapy.
Vorheriger Artikel Psychometric properties of the Minnesota Living with Heart Failure—Brazilian version—in the elderly
Nächster Artikel Validity, reliability and clinical relevance of EORTC QLQ-C30 and LC13 in patients with chest malignancies in a palliative setting

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Jetzt informieren
Literatur
1.
de Bruin, A. F., Diederiks, J. P., de Witte, L. P., et al. (1997). Assessing the responsiveness of a functional status measure: The sickness impact profile versus the SIP68. Journal of Clinical Epidemiology, 50, 529–540.PubMedCrossRef
2.
Kirshner, B., & Guyatt, G. (1985). A methodological framework for assessing health indices. Journal of Chronic Diseases, 38, 27–36.CrossRef
3.
Liang, M. H., Lew, R. A., Stucki, G., et al. (2002). Measuring clinically important changes with patient-oriented questionnaires. Medical Care, 40(4 Suppl), II45–51.PubMed
4.
Liang, M. H. (2000). Longitudinal construct validity: establishment of clinical meaning in patient evaluative instruments. Medical Care, 38(9 Suppl), II84–90.PubMed
5.
Cella, D., Bullinger, M., Scott, C., et al. (2002). Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life. Mayo Clinic Proceedings, 77, 384–392.PubMedCrossRef
6.
Kissane, D. W., Grabsch, B., Love, A., et al. (2004). Psychiatric disorder in women with early stage and advanced breast cancer: A comparative analysis. The Australian and New Zealand Journal of Psychiatry, 38, 320–326.PubMedCrossRef
7.
Lloyd-Williams, M., & Friedman, T. (2001). Depression in palliative care patients–a prospective study. European Journal of Cancer Care, 10, 270–274.CrossRef
8.
Zabora, J., BrintzenhofeSzoc, K., Curbow, B., et al. (2001). The prevalence of psychological distress by cancer site. Psychooncology, 10, 19–28.PubMedCrossRef
9.
Spiegel, D., & Bloom, J. R. (1983). Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosomatic Medicine, 45, 333–339.
10.
Spiegel, D., Bloom J. R., & Yalom, I. (1981). Group support for patients with metastatic cancer. A randomized outcome study. Archives of General Psychiatry, 38, 527–533.PubMed
11.
Cunningham, A. J., Edmonds, C. V., Jenkins, G. P., et al. (1998). A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology, 7, 508–517.PubMedCrossRef
12.
Edelman, S., Lemon, J., Bell, D. R., et al. (1999). Effects of group CBT on the survival time of patients with metastatic breast cancer. Psychooncology, 8, 474–481.PubMedCrossRef
13.
Goodwin, P. J., Leszcz, M., Ennis, M., et al. (2001). The effect of group psychosocial support on survival in metastatic breast cancer. The New England Journal of Medicine, 345, 1719–1726.PubMedCrossRef
14.
Hewitt, M., Herdman, R., & Holland, J. (Eds.) (2004). Meeting psychosocial needs of women with breast cancer (1st ed., p. 278). Washigton: The National Academy Press.
15.
Bordeleau, L., Szalai, J. P., Ennis, M., et al. (2003). Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data. Journal of Clinical Oncology, 21, 1944–1951.PubMedCrossRef
16.
Classen, C., Diamond, S., Soleman, A., et al. (1993). Brief supportive-expressive group therapy for women with primary breast cancer: A treatment manual. Stanford: Stanford University School of Medicine, p. 55.
17.
McNair D. L. M., & Droppleman, L. F. (1992). EdITS manual for the Profile of Mood States. San Diego, California 92167: EdITS/Educational and industrial testing service.
18.
Goodwin, P. J., Black, J. T., Bordeleau, L. J., et al. (2003). Health-related quality-of-life measurement in randomized clinical trials in breast cancer–taking stock. Journal of the National Cancer Institute, 95, 263–281.PubMedCrossRef
19.
Classen, C., Butler, L. D., Koopman, C., et al. (2001). Supportive-expressive group therapy and distress in patients with metastatic breast cancer: A randomized clinical intervention trial. Archives of General Psychiatry, 58, 494–501.PubMedCrossRef
20.
Taylor, S. E., Lichtman, R. R., Wood, J. V., et al. (1985). Illness-related and treatment-related factors in psychological adjustment to breast cancer. Cancer, 55, 2506–2513.PubMedCrossRef
21.
Watson, M., Greer, S., & Bliss, J. M. (1989) Mental Adjustment to Cancer (MAC) scale users’ manual.
22.
Andritsch, E., Goldzweig, G., Samonigg, H., et al. (2004). Changes in psychological distress of women in long-term remission from breast cancer in two different geographical settings: A randomized study. Support Care Cancer, 12, 10–18.PubMedCrossRef
23.
Watson, M., Haviland, J. S., Greer, S., et al. (1999). Influence of psychological response on survival in breast cancer: A population-based cohort study. Lancet, 354, 1331–1336.PubMedCrossRef
24.
Sundin, E. C., & Horowitz, M. J. (2003). Horowitz’s Impact of Event Scale evaluation of 20 years of use. Psychosomatic Medicine, 65, 870–876.CrossRef
25.
Kaasa, S., Malt, U., Hagen, S., et al. (1993). Psychological distress in cancer patients with advanced disease. Radiotherapy and Oncology, 27, 193–197.PubMedCrossRef
26.
Derogatis L. R., McNair D. M., The psychosocial adjustment to illness scale (PAIS & PAIS-SR). Administration, scoring & procedures manual-II. 1990, U.S.A.
27.
Friedman, L. C., Baer, P. E., Nelson, D. V., et al., (1988). Women with breast cancer: Perception of family functioning and adjustment to illness. Psychosomatic Medicine, 50, 529–540.PubMed
28.
Merluzzi, T. V., &. Martinez Sanchez. M. A., (1997). Factor structure of the psychosocial adjustment to illness scale (self-report) for persons with cancer. Psychological Assessment, 9, 269–276.
29.
Aaronson, N. K., Ahmedzai, S., Bergman, B., et al., (1993). The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.PubMedCrossRef
30.
Bottomley, A., Biganzoli, L., Cufer, T., et al., (2004). Randomized, controlled trial investigating short-term health-related quality of life with Doxorubicin and Paclitaxel versus Doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European organization for research and treatment of cancer breast cancer group, investigational drug branch for breast cancer and the new drug development group study. Journal of Clinical Oncology, 22, 2576–2586.PubMedCrossRef
31.
McLachlan, S. A., Devins G. M., & Goodwin, P. J. (1998). Validation of the European organization for research and treatment of cancer quality of life questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients. European Journal of Cancer, 34, 510–517.PubMedCrossRef
32.
Hjermstad, M. J., Fossa, S. D., Bjordal, K., et al., (1995). Test/retest study of the European organization for research and treatment of cancer core quality-of-life questionnaire. Journal of Clinical Oncology, 13, 1249–1254.PubMed
33.
Osoba, D., Rodrigues, G., Myles, J., et al., (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16, 139–144.PubMed
34.
Clark, P., Lavielle P., & Martinez, H., (2003). Learning from pain scales: Patient perspective. The Journal of Rheumatology, 30, 1584–1588.PubMed
35.
Cohen J., (1988). Statistical power analysis for the behavioral sciences. (2nd ed, p. 567). Hillsdale, New Jersey: Lawrence Erlbaum Associates.
36.
Samsa, G., Edelman, D., Rothman, M. L., et al., (1999). Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics, 15, 141–155.PubMedCrossRef
37.
Geels, P., Eisenhauer, E., Bezjak, A., et al., (2000). Palliative effect of chemotherapy: Objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. Journal of Clinical Oncology, 18, 2395–2405.PubMed
38.
Zou, G. Y., (2005). Quantifying responsiveness of quality of life measures without an external criterion. Quality of Life Research, 14, 1545–1552.PubMedCrossRef
39.
Lemieux, J., Beaton, D. E., S. Hogg-Johnson, et al., (2006). Three methods for minimally important difference: No relationship was found with the net proportion of patients improving. Journal of Clinical Epidemiology (in press).
40.
Schwartz, C. E., Bode, R., Repucci, N., et al., (2006). The clinical significance of adaptation to changing health: A meta-analysis of response shift. Quality of Life Research, 15, 1503–1508.PubMedCrossRef
41.
Holzner, B., Kemmler, G., Sperner-Unterweger, B., et al., (2001). Quality of life measurement in oncology–a matter of the assessment instrument? European Journal of Cancer, 37, 2349–2356.PubMedCrossRef
42.
Wilson, R. W., Hutson L. M., & Vanstry, D. (2005). Comparison of 2 quality-of-life questionnaires in women treated for breast cancer: The RAND 36-Item Health Survey and the Functional Living Index-Cancer. Physical Therapy, 85, 851–860.PubMed
Metadaten
Titel
Responsiveness to change to change due to supportive-expressive group therapy, improvement in mood and disease progression in women with metastatic breast cancer
verfasst von
Julie Lemieux
Dorcas E. Beaton
Sheilah Hogg-Johnson
Louise J. Bordeleau
Jon Hunter
Pamela J. Goodwin
Publikationsdatum
01.08.2007
Verlag
Springer Netherlands
Erschienen in
Quality of Life Research / Ausgabe 6/2007
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-007-9208-2

Weitere Artikel der Ausgabe 6/2007

Quality of Life Research 6/2007 Zur Ausgabe

Original Paper

Life satisfaction decreases during adolescence

Original Paper

Differential item functioning impact in a modified version of the Roland–Morris Disability Questionnaire

Book Review

Rod O’Connor: Measuring quality of life in health

OriginalPaper

Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report

Original Paper

Effect of trauma on quality of life as mediated by mental distress and moderated by coping and social support among postconflict displaced Ethiopians

Erratum

Factors associated with health-related quality of life among hemodialysis patients in the DOPPS

Premium Partner

    Bildnachweise